Therapeutic compound and treatments
View Patent ↗Compositions and uses associated with the MT477 family of compounds are disclosed. Particular structural features and properties of the compounds are described in detail. Uses include administering an MT477 family member to a patient for therapeutic purposes. Compositions include chemicals belonging to the MT477 family and pharmaceuticals that contain such chemicals.
1. A method for treating a cancer selected from leukemia, non-small cell lung cancer, colon cancer, CNS cancer. melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer, and pancreatic cancer in a patient, comprising administering to said patient a therapeutically effective amount of a compound selected from
or a pharmaceutically acceptable salt thereof.
2. A method for treating a cancer selected from leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer, and pancreatic cancer in a patient comprising administering to said patient a therapeutically effective amount of a compound having a structure
or a pharmaceutically acceptable salt thereof.
3. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound selected from
or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound having a structure
or a pharmaceutically acceptable salt thereof.
5. The pharmaceutical composition of claim 3 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
6. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
7. A method for treating a cancer selected from leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer, and pancreatic cancer in a patient, comprising administering to said patient a pharmaceutical composition of claim 3 , 4 , or 5 .
8. The method of any one of claims 1 , 2 , or 6 , wherein the cancer is non-small cell lung cancer.
9. The method of any one of claims 1 , 2 , or 6 , wherein the cancer is pancreatic cancer.
10. The method of claim 7 , wherein the cancer is non-small cell lung cancer.
11. The method of claim 7 , wherein the cancer is pancreatic cancer.